scholarly journals News

2021 ◽  
Vol 18 (4) ◽  
pp. 331-332
Author(s):  
Article Editorial

FDA APPROVED THE MEDICATION FOR SKIN ITCHING ASSOCIATED WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS.ADVANCES IN TYPE 2 DIABETES MANAGEMENT IN CHILDREN.FIRST ORAL MEDICATION FOR THE TREATMENT OF CHILDREN WITH MULTIPLE SCLEROSIS WAS APPROVED.THE WORLD'S FIRST MEDICATION FOR THE TREATMENT OF SHORT BOWEL SYNDROME WAS REGISTERED IN RUSSIAN FEDERATION.

2019 ◽  
Vol 5 (6) ◽  
pp. e375-e379
Author(s):  
Mimi Wong ◽  
Luke Conway ◽  
Caroline Cooper ◽  
Ashim Sinha ◽  
Nirjhar Nandi

Objective: Adult nesidioblastosis is characterized by endogenous hyperinsulinemia typically causing post-prandial hypoglycemia, and most commonly occurs post-Roux-en-Y gastric bypass. Methods: We report a unique case of nesidioblastosis occurring in a 67-year-old female. Results: A 5-year history of symptomatic hypoglycemia occurred in a patient with short bowel syndrome and type 2 diabetes mellitus (T2DM) managed previously with a glucagon-like peptide 1 (GLP-1) agonist, which achieved significant weight loss. Continuous glucose monitoring captured 42 hypoglycemia episodes in a 2-week period, and following an oral glucose tolerance test there was the suggestion of a hyperinsulinemia state. She was managed with an open distal pancreatectomy, and subsequently required medical therapy to maintain euglycemia. Conclusion: We present the first case of nesidioblastosis occurring in a patient with short bowel syndrome, pre-existing T2DM managed with a GLP-1 agonist which achieved significant weight loss, all of which we speculate could have predisposed to hypoglycemia and development of nesidioblastosis.


Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 1584-P
Author(s):  
JUAN J. GAGLIARDINO ◽  
PABLO ASCHNER ◽  
HASAN M. ILKOVA ◽  
FERNANDO J. LAVALLE-GONZALEZ ◽  
AMBADY RAMACHANDRAN ◽  
...  

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1311-P
Author(s):  
XIN CHEN ◽  
GAIL FERNANDES ◽  
JIE CHEN ◽  
ZHIWEN LIU ◽  
RICHARD BAUMGARTNER

2021 ◽  
pp. 155982762110024
Author(s):  
Alyssa M. Vela ◽  
Brooke Palmer ◽  
Virginia Gil-Rivas ◽  
Fary Cachelin

Rates of type 2 diabetes mellitus continue to rise around the world, largely due to lifestyle factors such as poor diet, overeating, and lack of physical activity. Diet and eating is often the most challenging aspect of management and, when disordered, has been associated with increased risk for diabetes-related complications. Thus, there is a clear need for accessible and evidence-based interventions that address the complex lifestyle behaviors that influence diabetes management. The current study sought to assess the efficacy and acceptability of a pilot lifestyle intervention for women with type 2 diabetes and disordered eating. The intervention followed a cognitive behavioral therapy guided-self-help (CBTgsh) model and included several pillars of lifestyle medicine, including: diet, exercise, stress, and relationships. Ten women completed the 12-week intervention that provided social support, encouraged physical activity, and addressed eating behaviors and cognitions. Results indicate the lifestyle intervention was a feasible treatment for disordered eating behaviors among women with type 2 diabetes and was also associated with improved diabetes-related quality of life. The intervention was also acceptable to participants who reported satisfaction with the program. The current CBTgsh lifestyle intervention is a promising treatment option to reduce disordered eating and improve diabetes management.


2020 ◽  
Vol 70 (6) ◽  
pp. e139-e140
Author(s):  
Marion Almes ◽  
Agathe Jobert ◽  
Martine Lapalus ◽  
Elodie Mareux ◽  
Emmanuel Gonzales ◽  
...  

2014 ◽  
Vol 164 (5) ◽  
pp. 1219-1227.e3 ◽  
Author(s):  
Sotaro Naoi ◽  
Hisamitsu Hayashi ◽  
Takeshi Inoue ◽  
Ken Tanikawa ◽  
Koji Igarashi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document